Previous 10 | Next 10 |
home / stock / ew / ew articles
On Tuesday, February 13, 2024, the FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet regar...
Edwards Lifesciences Corporation (NYSE: EW) reported in-line earnings for its fourth quarter on Tuesday. Edwards Lifesciences posted adjusted earni...
U.S. stocks are poised for another day of weakness, although some positive tech earnings may provide a modest lift to the sector. The market appe...
Edwards Lifesciences Corporation (NYSE: EW) shares traded higher on Wednesday. The stock surged despite any company-specific news. What To Know: Ed...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 15 years by 8.14% on an annualized basis producing an average annual retur...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 11.1% on an annualized basis producing an average annual retur...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 20 years by 10.52% on an annualized basis producing an average annual retu...
U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Tuesday. Shares of Zscaler, Inc. (NASDAQ: ZS)...
Edwards Lifesciences (NYSE:EW) has outperformed the market over the past 10 years by 10.52% on an annualized basis producing an average annual retu...
News, Short Squeeze, Breakout and More Instantly...
Edwards Lifesciences Corporation Company Name:
EW Stock Symbol:
NYSE Market:
Edwards Lifesciences Corporation Website:
Vancouver, British Columbia--(Newsfile Corp. - June 19, 2024) - East West Petroleum Corp. (TSXV: EW) ("East West" or the "Company") announces that the Board of directors has determined that its in the best interest of the Company to return capital to its shareholders by way of a reduction in st...
Edwards Lifesciences (NYSE: EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through five-year follow up of more than 1,300 low and intermediate risk SAPIEN 3 valve p...
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader PR Newswire Combination unlocks new future value-creation opportunities and is expected to be immed...